CGTN published this video item, entitled “Interview with CanSinoBIO’s CEO: Get to know China’s first single-dose vaccine” – below is their description.
For more:
China’s first Ad5-nCoV COVID-19 vaccine, produced by CanSino Biologics Inc., was rolled out on February 25. It is the only single-dose COVID-19 vaccine given conditional approval for rollout in China. But what is an Ad5-nCoV vaccine? What’s the difference between the single-dose vaccine and the double-dose vaccines? And will those vaccinated be immune to mutated strains of the virus?
CGTN YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.